Markets

Insider Trading

Hedge Funds

Retirement

Opinion

15 Most Common Addictions In The US

In this article, we will take a look at the 15 most common addictions in the US. If you want to skip our detailed analysis, you can go directly to the 5 Most Common Addictions In The US.

Current State of Legalization of Cannabis in the US

Marijuana or cannabis use is one of the most widely spread addictions in the US. According to the results of the 2022 National Survey on Drug Use and Health, in 2022, 22% of people aged twelve and more misused cannabis in some form. Cannabis is available in a variety of states and the user can smoke, vape, or digest it with some food or drink. The use of cannabis was the highest among people aged between eighteen and twenty-five. Smoking was the most common mode for taking marijuana during this year.

2023 was a relatively tumultuous year for the cannabis industry as the industry was met with fierce competition from the illicit market. Illegal manufacturing and distribution of cannabis caused the overall market and retail sales to slump. The overall situation of the cannabis market stirred support for the legalization of the drug in the US.

On January 9, Reuters reported that the most notable effort made in this regard in 2023 was by the Department of Health and Human Services. HHS recommended to the US Drug Enforcement Agency to reclassify cannabis from Schedule I of the Controlled Substances Act (CSA) to Schedule III. The reclassification of the drug would alter the legal status of cannabis and recognition by the federal government. Schedule I includes substances with a high potential for abuse, no accepted medical use, and a lack of accepted safety for use under medical supervision. However, Schedule III substances still have a potential for abuse, but they have accepted medical uses and are considered to have a moderate to low potential for dependence or abuse.

The reclassification would be the most notable change in the US cannabis policy as it will change the status of the drug from being prohibited to being regulated. The reclassification would be beneficial for the overall cannabis industry. Section 280E of the Internal Revenue Code restricts cannabis businesses from deducting ordinary business expenses when calculating their taxable income. After the reclassification, this section would no longer apply resulting in lower taxable income and reduced tax liability. In the US, twenty-five states including Ohio, Minnesota, and Delaware have legalized recreational cannabis. Public support for the legalization is also rising and is expected to fuel the growth of the cannabis market in the country. You can also check out the 25 Most Cannabis Consuming-Countries in the World.

Notable Names in the Cannabis Industry

The legalization of cannabis could potentially alter the course of the overall cannabis industry. There are prominent names already present in the industry including Aurora Cannabis Inc (NASDAQ:ACB), Canopy Growth Corp (NASDAQ:CGC), and Cronos Group Inc. (NASDAQ:CRON). You can also read about the 11 Best Cannabis Stocks To Buy Now.

Aurora Cannabis Inc (NASDAQ:ACB) is a Canadian licensed cannabis producer. The company was founded in December 2006 and is headquartered in Edmonton. On January 24, the company announced the launch of three new cannabis-infused beverages. The products have been designed to cater to the needs of patients who want alternative forms of cannabis. The beverages would be initially available only to veteran patients on the Aurora Medical website. The newly introduced flavors by Aurora Cannabis Inc (NASDAQ:ACB) include Neon Rush, Strawberry Pineapple Tropical Fizz, and Pineapple Coconut Fizz.

Canopy Growth Corp (NASDAQ:CGC) was formerly known as Tweed Marijuana Inc. Canopy Growth Corp (NASDAQ:CGC) is a Canadian company headquartered in Smiths Falls, Canada. On January 24, the company announced the launch of new products in its adult use and medical cannabis portfolio, including Tweed soft gels and oils with minor cannabinoids, a large format flower from Tweed, and medical exclusive pre-rolls from 7ACRES and Spectrum Therapeutics. The products are available through legal channels and online platforms. Terpene and cannabinoid levels vary in the products.

Cronos Group Inc. (NASDAQ:CRON) is a notable Canadian cannabis company that engages in the production and distribution of cannabis products. On January 9, Cronos Group Inc. (NASDAQ:CRON) announced that it will be entering the Australian market by shipping its first batch of cannabis flowers to Vitura Health Limited (ASX:VIT). The move aims to tap into Australia’s growing medical cannabis market. The company’s investment in R&D and genetics breeding aims to offer premium genetics tailored for Vitura’s patients.

Cannabis is one of the most common addictions in the US. However, it is one among many others. We have made a list of the most common addictions in the US.

15 Most Common Addictions In The US

Our Methodology 

To make our list of the 15 most common addictions in the US we have used the data from Substance Abuse and Mental Health Services Administration. The data has been extracted from the results of the 2022 National Survey on Drug Use and Health. The survey presented a large number of drugs and the number of people who misused that drug in a certain year. We went through the report and extracted the names of the drugs with the most number of users. There is a strong correlation between an increased incidence of drug misuse and the prevalence of addiction. We have narrowed down the list to the fifteen most common addictions in the US. The subsequent list has been arranged in ascending order based on the number of users. The data for 2022 is the latest available version for the number of drug users, however, it is apt in gauging the overall situation of various addictions in the US. The stats are for people aged 12 or older in 2022.

By the way, Insider Monkey is an investing website that tracks the movements of corporate insiders and hedge funds. By using a consensus approach, we identify the best stock picks of more than 900 hedge funds investing in US stocks. The top 10 consensus stock picks of hedge funds outperformed the S&P 500 Index by more than 140 percentage points over the last 10 years (see the details here). Whether you are a beginner investor or a professional one looking for the best stocks to buy, you can benefit from the wisdom of hedge funds and corporate insiders.

15 Most Common Addictions In The US

15. Heroine

Number of Users in 2022: 1 Million

Heroine use is one of the most common addictions in the US. The use of heroin was the most common among adults aged 26 or older. Heroine is a highly addictive drug and long-term use can have a dire impact on the health of the user. The drug has been even noted to change the brain structure caused by consistent use.

14. Fentanyl

Number of Users in 2022: 1.9 Million

Fentanyl is among the most commonly used drugs in the US with a staggering number of 1.9 million users in 2022. The drug is used medically to ease pain. The drug has similar impacts to morphine, however, it has been noted to be 50 to 100 times more potent. The illegal production and distribution of the drug is fuelling the growing addiction.

13. Kratom

Number of Users in 2022: 1.9 Million

Kratom use is one of the most prevalent addictions in the US. The drug is made from the leaves of a tree that is native to Southeast Asia. The drug is available in the form of powder, pills, and leaves. The use of kratom has a mind-altering effect. The long-term use of the drug could have serious health impacts on the health of the user.

12. Inhalant

Number of Users in 2022: 2.3 Million

The use of inhalants is becoming increasingly common in the US with an alarming 2.3 million users in 2022. Inhalants include a wide range of substances including paint thinners, gasoline, glues, deodorant and hair sprays, and fabric protector sprays. People use different inhalants to get high, however, these substances have detrimental impacts on the health of the users.

11. Methamphetamine

Number of Users in 2022: 2.7 Million

Methamphetamine use is one of the most common addictions in the US. Even though methamphetamine is available as a prescription drug in the country the majority of the production and distribution takes place illicitly. The drug is highly addictive and has a severe impact on the health of the user.

10. Prescription Stimulants

Number of Users in 2022: 4.3 Million

Prescription stimulants are a class of drugs that enhance brain activity. The drug is generally prescribed for health conditions including attention-deficit hyperactivity disorder (ADHD). However, the number of people who misuse prescription stimulants is alarmingly high. In 2022, 4.3 million people misused prescription stimulants.

9. Prescription Tranquilizer or Sedative

Number of Users in 2022: 4.8 Million

The misuse of prescription tranquilizers or sedatives is also a common addiction in the US. In 2022, 4.8 million people abused these drugs mainly through illicit distribution and acquisition. The drug is used to induce sleep and relax muscles however the long-term use could severely impact the health of the user.

8. Cocaine

Number of Users in 2022: 5.3 Million

Cocaine is a powerful stimulant drug that comes from the leaves of the coca bush native to South America. Cocaine is a fine white crystal powder that is generally inhaled. The drug is highly addictive and long-term use can alter brain activity.

7. Hallucinogens

Number of Users in 2022: 8.5 Million

Hallucinogens are a diverse class of psychoactive drugs that can produce altered states of consciousness. Some well-known hallucinogens include LSD, psilocybin, and DMT. The drug user experiences an alternate state of reality that can have a long-term impact on the user. The use of hallucinogens in any quantity is deemed unsafe.

6. Prescription Pain Relievers

Number of Users in 2022: 8.5 Million

The regular use of prescription pain relievers is one of the rising addictions in the US. In 2022, an astounding 8.5 million people misused the drug. Prescription painkillers are misused by illicit distribution. Repeated use of painkillers can have serious health consequences.

Click to continue reading and see the 5 Most Common Addictions In The US.

Suggested articles:

Disclosure: None. 15 Most Common Addictions In The US is originally published on Insider Monkey.

AI Fire Sale: Insider Monkey’s #1 AI Stock Pick Is On A Steep Discount

Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a steal!

The whispers are turning into roars.

Artificial intelligence isn’t science fiction anymore.

It’s the revolution reshaping every industry on the planet.

From driverless cars to medical breakthroughs, AI is on the cusp of a global explosion, and savvy investors stand to reap the rewards.

Here’s why this is the prime moment to jump on the AI bandwagon:

Exponential Growth on the Horizon: Forget linear growth – AI is poised for a hockey stick trajectory.

Imagine every sector, from healthcare to finance, infused with superhuman intelligence.

We’re talking disease prediction, hyper-personalized marketing, and automated logistics that streamline everything.

This isn’t a maybe – it’s an inevitability.

Early investors will be the ones positioned to ride the wave of this technological tsunami.

Ground Floor Opportunity: Remember the early days of the internet?

Those who saw the potential of tech giants back then are sitting pretty today.

AI is at a similar inflection point.

We’re not talking about established players – we’re talking about nimble startups with groundbreaking ideas and the potential to become the next Google or Amazon.

This is your chance to get in before the rockets take off!

Disruption is the New Name of the Game: Let’s face it, complacency breeds stagnation.

AI is the ultimate disruptor, and it’s shaking the foundations of traditional industries.

The companies that embrace AI will thrive, while the dinosaurs clinging to outdated methods will be left in the dust.

As an investor, you want to be on the side of the winners, and AI is the winning ticket.

The Talent Pool is Overflowing: The world’s brightest minds are flocking to AI.

From computer scientists to mathematicians, the next generation of innovators is pouring its energy into this field.

This influx of talent guarantees a constant stream of groundbreaking ideas and rapid advancements.

By investing in AI, you’re essentially backing the future.

The future is powered by artificial intelligence, and the time to invest is NOW.

Don’t be a spectator in this technological revolution.

Dive into the AI gold rush and watch your portfolio soar alongside the brightest minds of our generation.

This isn’t just about making money – it’s about being part of the future.

So, buckle up and get ready for the ride of your investment life!

Act Now and Unlock a Potential 10,000% Return: This AI Stock is a Diamond in the Rough (But Our Help is Key!)

The AI revolution is upon us, and savvy investors stand to make a fortune.

But with so many choices, how do you find the hidden gem – the company poised for explosive growth?

That’s where our expertise comes in.

We’ve got the answer, but there’s a twist…

Imagine an AI company so groundbreaking, so far ahead of the curve, that even if its stock price quadrupled today, it would still be considered ridiculously cheap.

That’s the potential you’re looking at. This isn’t just about a decent return – we’re talking about a 10,000% gain over the next decade!

Our research team has identified a hidden gem – an AI company with cutting-edge technology, massive potential, and a current stock price that screams opportunity.

This company boasts the most advanced technology in the AI sector, putting them leagues ahead of competitors.

It’s like having a race car on a go-kart track.

They have a strong possibility of cornering entire markets, becoming the undisputed leader in their field.

Here’s the catch (it’s a good one): To uncover this sleeping giant, you’ll need our exclusive intel.

We want to make sure none of our valued readers miss out on this groundbreaking opportunity!

That’s why we’re slashing the price of our Premium Readership Newsletter by a whopping 75%.

For a ridiculously low price of just $24, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single restaurant meal!

Here’s why this is a deal you can’t afford to pass up:

  • The Name of the Game-Changing AI Stock: Our in-depth report dives deep into our #1 AI stock’s groundbreaking technology and massive growth potential.
  • Ad-Free Browsing: Enjoy a year of investment research free from distracting banner and pop-up ads, allowing you to focus on uncovering the next big opportunity.
  • Lifetime Money-Back Guarantee:  If you’re not absolutely satisfied with our service, we’ll provide a full refund ANYTIME, no questions asked.

 

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

  1. Head over to our website and subscribe to our Premium Readership Newsletter for just $24.
  2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.
  3. Sit back, relax, and know that you’re backed by our ironclad lifetime money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Subscribe Now!

A New Dawn is Coming to U.S. Stocks

I work for one of the largest independent financial publishers in the world – representing over 1 million people in 148 countries.

We’re independently funding today’s broadcast to address something on the mind of every investor in America right now…

Should I put my money in Artificial Intelligence?

Here to answer that for us… and give away his No. 1 free AI recommendation… is 50-year Wall Street titan, Marc Chaikin.

Marc’s been a trader, stockbroker, and analyst. He was the head of the options department at a major brokerage firm and is a sought-after expert for CNBC, Fox Business, Barron’s, and Yahoo! Finance…

But what Marc’s most known for is his award-winning stock-rating system. Which determines whether a stock could shoot sky-high in the next three to six months… or come crashing down.

That’s why Marc’s work appears in every Bloomberg and Reuters terminal on the planet…

And is still used by hundreds of banks, hedge funds, and brokerages to track the billions of dollars flowing in and out of stocks each day.

He’s used this system to survive nine bear markets… create three new indices for the Nasdaq… and even predict the brutal bear market of 2022, 90 days in advance.

Click to continue reading…